Abstract:Background/aim: Depressive disorders are multifactorial diseases, in which cognitive impairment is one of the characteristic feature. One of the molecules that regulate of various cognitive, emotional and behavioural processes is nitric oxide (NO), synthesized from L-arginine by a family of isoformic enzymes known as nitric oxide synthases (NOS). NO is a gaseous compounds that acts as a biological second messenger in a number of organ system. In addition, NO is a ubiquitous free radical ((NO)-N-center dot) that affects many normal physiologic functions but is also implicated in the etiology and progression of many diseases. The aim of the study was to determine the concentration of NO in patients with recurrent depressive disorder (rDD) and to define relationship between plasma NO levels and the cognitive performance.Methods: The study comprised 78 subjects: patients with rDD (n = 45), healthy controls (CG, n = 33). Cognitive function assessment was based on: TMT, The Stroop Test, VFT, AVLT.Results: Statistically significant differences were found among patients with rDD in the intensity of depression symptoms, measured by the HORS on therapy onset vs. the examination results after 8 weeks of treatment (p < 0.001). The level of NO was substantially higher in patients with rDD compared to CG. For all examined subjects (p < 0.001), elevated levels of NO in blood plasma adversely affect the efficiency of visual-spatial and auditory-verbal working memory as well as short-term declarative memory. For rDD patients, elevated NO levels were associated with worse cognitive test performance. The higher was the concentration of plasma NO, the greater was the severity of depressive symptoms measured by HDRS (p = 0.03).Conclusions: (1) Higher concentration of plasma NO in rDD patients is associated with the severity of depressive symptoms. (2) Elevated levels of plasma NO are related to impairment of visual-spatial and auditory-verbal working memory as well as to impairment of short-term declarative memory. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

Nitric Oxide Plasma Concentration Associated with Cognitive Impairment in Patients with Recurrent Depressive Disorder

The Changes In, and Relationship Between, Plasma Nitric Oxide and Corticotropin‐releasing Hormone in Patients with Major Depressive Disorder

The Association Between Plasma Neurotransmitters Levels and Depression in Acute Hemorrhagic Stroke

Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder.

Malondialdehyde Plasma Concentration Correlates with Declarative and Working Memory in Patients with Recurrent Depressive Disorder

Total Antioxidant Status Correlates with Cognitive Impairment in Patients with Recurrent Depressive Disorder

Manganese superoxide dismutase gene expression and cognitive functions in recurrent depressive disorder.

An inducible nitric oxide synthase polymorphism is associated with the risk of recurrent depressive disorder.

Decreased Plasma Neuroactive Amino Acids and Increased Nitric Oxide Levels in Melancholic Major Depressive Disorder.

Empirical evidence for the neurocognitive effect of nitrous oxide as an adjunctive therapy in patients with treatment resistant depression: a randomized controlled study

Procognitive activity of nitric oxide inhibitors and donors in animal models

Secondary analysis of neurotransmitter metabolism and cognitive function in first-diagnosed, drug-naïve adult patients with major depressive disorder

Activation of Hippocampal Neuronal NADPH Oxidase NOX2 Promotes Depressive-Like Behaviour and Cognition Deficits in Chronic Restraint Stress Mouse Model

Decreased NOS1 expression in the anterior cingulate cortex in depression.

Use of nitrous oxide in the treatment of major depressive disorder and treatment-resistant major depressive disorder: A systematic review and meta-analysis nitrous oxide in depressive disorders

Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease

Nitrous Oxide Alters Functional Connectivity in Medial Limbic Structures in Treatment-Resistant Major Depression

Association Study Between Plasma GDNF and Cognitive Function in Late-Onset Depression.

Arginine metabolomics in mood disorders

Neurofilament light chain plasma levels in major depressive disorder: a brief research report